01 / FAST-MELT COMPOSITION
Rapid Salivary Disintegration
Engineered with superdisintegrants and micro-fine excipients to melt smoothly on the tongue within 30 seconds without gritty residue, facilitating pre-gastric mucosal absorption.
Blessme · Anti-Panic & Anxiolytics
Clonazepam MD Tablets - DELOTRIL (0.25 mg)
DELOTRIL-0.25 is a fast-acting Clonazepam Mouth Dissolving Tablets IP 0.25 mg formulation by Blessme, the dedicated neuro-psychiatric division of Dellwich Lifescience LLP. Formulated with rapid-melt technology for quick disintegration without water, DELOTRIL-0.25 offers prompt control over acute panic attacks, generalized anxiety, and seizure episodes for hospitals and PCD franchise distributors across India.
Fast-Melt MD Formulation
Schedule H Prescription
Pan-India Supply
Product SpecificationsAbout Clonazepam MD 0.25 mg
About Clonazepam MD 0.25 mg
(DELOTRIL-0.25)
Comprehensive pharmaceutical specifications, mouth-dissolving tablet attributes, active API data, and regulatory classification for DELOTRIL-0.25.
Blessme · Anti-Panic / Anticonvulsants
Clonazepam MD 0.25 mg - DELOTRIL
Clonazepam Mouth Dissolving Tablets IP 0.25 mg (DELOTRIL-0.25) is a high-affinity benzodiazepine formulation crafted to dissolve instantly in the oral cavity. Ideal for rapid anxiolysis, panic attack termination, and gentle dose titration under registered medical supervision.
Fast Mouth-Dissolving Technology (No Water Needed)Rapid Relief in Acute Panic Attacks & Agoraphobia Gentle 0.25 mg Starting Dose for Minimal Sedation Adjunctive Treatment in Epileptic Seizures Strict Indian Pharmacopoeia Quality Compliance
- Product Brand Name
- DELOTRIL-0.25
- Active Pharmaceutical Ingredient
- Clonazepam IP (0.25 mg)Verified IP
- Dosage Formulation
- Mouth Dissolving Tablet (MD / ODT)
- Therapeutic Class
- High-Potency Benzodiazepine / Anxiolytic / Anti-Panic / Anticonvulsant
- Strength
- 0.25 mg per tablet
- Standard Packaging
- 5x4x10 (200 Tablets) Blister Pack
- Regulatory Category
- Schedule H Prescription Drug
- Marketing Division
- Blessme · Neuro & Psychiatric Products
- Marketing & Distribution Company
- Dellwich Lifescience LLP, Ahmedabad, Gujarat
- Storage Condition
- Store protected from light and moisture at a temperature below 25°C
- Quality Standard
- Manufactured in WHO-GMP & ISO 9001:2015 Certified Units
- Country of Origin
- India
Clinical & Commercial MonographClonazepam MD Tablet 0.25 mg & DELOTRIL
Clonazepam MD Tablet 0.25 mg & DELOTRIL
Complete Medical & Supply Guide
Everything you need to know about Clonazepam Mouth Dissolving Tablets IP 0.25 mg, marketed under the brand name DELOTRIL-0.25 by Blessme (Dellwich Lifescience LLP). Features pharmacodynamics, sublingual kinetics, panic disorder treatment protocols, and B2B pharmaceutical supply.
What is Clonazepam MD Tablet (DELOTRIL-0.25)?
Clonazepam MD tablet is a specialized orally disintegrating pharmaceutical formulation containing Clonazepam IP, a potent and long-acting benzodiazepine. Unlike traditional tablets that require water and take time to disintegrate in the stomach, MD (mouth dissolving) tablets disintegrate in saliva within seconds.
When patients experience a sudden surge of acute panic, breathless apprehension, or agoraphobia, having access to an oral tablet that acts swiftly without drinking water is vital. DELOTRIL-0.25 provides this convenience, ensuring rapid mucosal contact and accelerated calming action.
Clinical Indications of Clonazepam MD 0.25 mg
Clonazepam MD tablet uses span critical neurological and psychiatric conditions:
- Panic Disorder: Rapid abortive treatment and prophylactic management of recurrent panic attacks with or without agoraphobia.
- Generalized Anxiety Disorder (GAD): Rapid alleviation of chronic apprehension, motor tension, and autonomic hyperactivity.
- Epileptic Seizures: Effective oral adjunctive therapy in akinetic and myoclonic seizures, absence seizures (petit mal), and Lennox-Gastaut syndrome.
- Initial Dosage Titration: Serves as the optimal low-dose starting regimen to acclimate patients and evaluate tolerance.
- Restless Legs Syndrome (RLS): Off-label clinical utility in reducing nocturnal motor restlessness.
Neurochemical Mechanism of Action & Sublingual Absorption
Clonazepam exhibits exceptionally high binding affinity for benzodiazepine receptors on the GABAA receptor-chloride ionophore complex in the limbic system, brainstem reticular formation, and cerebral cortex. By allosterically enhancing GABA binding, it accelerates chloride ion channel opening frequencies, inducing deep neuronal hyperpolarization.
The Mouth Dissolving (MD) formulation allows a portion of the active Clonazepam molecule to be absorbed directly through the sublingual and buccal vasculature. This bypasses first-pass hepatic degradation, producing a faster onset of clinical tranquillity compared to standard swallowable tablets.
Why Choose 0.25 mg Strength for Starting Therapy?
Clinical advantages of the 0.25 mg dosage in neuropsychiatric practice:
- Reduced Sedation: Minimizes day-time drowsiness, fatigue, and psychomotor impairment compared to higher starting doses.
- Elderly & Sensitive Patients: Provides an ideal safety profile for geriatric populations susceptible to ataxia and fall injuries.
- Precision Micro-Dosing: Allows physicians to gradually titrate upwards to 0.5 mg (DELOTRIL-0.5) only when clinically justified.
- Easy Tapering: Facilitates seamless dosage reduction when gradually discontinuing long-term therapy.
Dosage Guidelines & Administration Method
DELOTRIL-0.25 must be administered under registered medical guidance:
- Administration: Place the tablet on the tongue. Allow it to dissolve in saliva and swallow without water.
- Panic Disorder Starting Dose: Initial adult dose is typically 0.25 mg twice daily, which may be increased after 3 days if necessary.
- Maintenance Dosing: Most patients achieve stabilization between 0.5 mg to 1 mg daily in divided doses.
- Maximum Duration: Best prescribed for short-to-medium term stabilization to prevent tolerance and dependence.
Clonazepam MD Tablet Brands in India & DELOTRIL Advantage
While several brands market Clonazepam in India (such as Clonafit, Zapiz, and Epitril), DELOTRIL-0.25 by Blessme has established strong clinical preference due to:
- Instant Disintegration Profile: Formulated for complete oral disintegration within 30 seconds.
- Moisture-Resistant Blister Strips: Preserves tablet hardness without crumbling in high-humidity climates.
- WHO-GMP Certified Batch Assay: Certified active content conforming to Indian Pharmacopoeia standards.
- Direct PCD Distribution: Attractive profit margins with district-wise monopoly protection.
Side Effects, Precautions & Safe Usage
Essential clinical warnings for healthcare professionals and patients:
- Common Reactions: Somnolence, lightheadedness, impaired coordination, and fatigue.
- Avoid Alcohol & Opioids: Concurrent intake of central nervous system depressants poses severe risks of respiratory arrest.
- Tapering Requirement: Never stop treatment abruptly; sudden cessation may trigger rebound anxiety, tremors, or withdrawal seizures.
- Contraindications: Severe respiratory depression, narrow-angle glaucoma, and severe liver disease.
Critical Safety Warning - Schedule H Controlled Psychotropic Substance
Clonazepam is a potent benzodiazepine with significant potential for habit formation, tolerance, and physical dependence. Long-term use should be carefully monitored. DELOTRIL-0.25 is supplied strictly against a valid medical prescription from a registered medical practitioner.
Quality & Production
Pharmaceutical Quality Assurance & Compliance
DELOTRIL-0.25 is manufactured in advanced automated pharmaceutical facilities adhering to WHO-GMP, ISO 9001:2015, and Schedule M standards, ensuring exceptional fast-melt uniformity and batch-to-batch consistency.
02 / HIGH-BARRIER PACK
Foil Blister Integrity
Packaged in moisture-impermeable blister cavities to safeguard the hygroscopic fast-dissolving matrix from ambient air humidity and mechanical crumbling during transit.
03 / ANALYTICAL TESTING
COA & Disintegration Assay
Strict pharmacopoeial testing guarantees uniform drug dispersion, fast disintegration compliance, and precise 0.25 mg active Clonazepam IP assay per unit.
04 / PRODUCTION STANDARDS
WHO-GMP & Schedule M
Manufactured in state-of-the-art climate-controlled compression suites adhering to WHO-GMP, ISO 9001:2015, and Good Laboratory Practices (GLP).
Clinical Profile & Precautions
Approved Indications & Regulatory Guidelines
As a Schedule H controlled benzodiazepine medication, Clonazepam MD requires responsible clinical oversight, patient counseling, and adherence to prescription mandates.
Prescription-Only Schedule H Medication Notice
DELOTRIL-0.25 contains Clonazepam IP 0.25 mg. To be sold by retail on the prescription of a Registered Medical Practitioner only. Do not exceed prescribed duration. Caution is advised when driving motor vehicles or handling complex machinery.
Clinical Indications Profile
Approved neurological and psychiatric indications for Clonazepam MD 0.25 mg (DELOTRIL-0.25):
- Panic Attacks & Agoraphobia: Rapid suppression of intense situational fear and cardiovascular panic symptoms.
- Generalized Anxiety Disorder: Daytime tranquilization without overwhelming sedation.
- Myoclonic & Absence Seizures: Oral anticonvulsant management in childhood and adult epilepsies.
- Social Phobia: Short-term symptomatic relief of severe anticipatory anxiety.
- Elderly Anxiolysis: Safe micro-dose starting therapy for geriatric populations.
Pharmacology & Clinical Precautions
Key pharmacokinetic parameters and patient monitoring guidelines:
- Mechanism: Positive allosteric modulation of GABA_A chloride channel conductance.
- Drug Interactions: Additive CNS depression when taken with alcohol, sedatives, or tricyclic antidepressants.
- Hepatic Metabolism: Metabolized primarily by CYP3A4 into 7-amino-clonazepam; dose reduction is advised in liver dysfunction.
- Pregnancy Category D: Potential risks of congenital malformations; avoid use during pregnancy and lactation unless strictly essential.
Manufacturing & Marketing
Dellwich Lifescience LLPBlessme · Neuro & Psychiatric Division
About Dellwich Lifescience
Trusted Neuro & Psychiatric Pharmaceutical Manufacturer in Ahmedabad, Gujarat
Dellwich Lifescience LLP is an established pharmaceutical company based in Science City, Ahmedabad, Gujarat, dedicated to advanced formulation technology, uncompromising quality assurance, and ethical healthcare supply. Through our specialized neurology division, Blessme, we manufacture and market superior neuro-psychiatric treatments, including DELOTRIL-0.25 (Clonazepam MD Tablets IP 0.25 mg).
We support PCD pharma franchise partners, hospital supply chains, and contract manufacturing clients across India with guaranteed supply security, validated product dossiers, and prompt dispatch.
Commercial PartnershipsDELOTRIL-0.25 Supply &
DELOTRIL-0.25 Supply &
Pharmaceutical Distribution
Whether you are seeking DELOTRIL-0.25 (Clonazepam MD Tablets IP 0.25 mg) for district monopoly PCD franchise distribution, third-party contract manufacturing, or hospital bulk procurement, Dellwich Lifescience LLP delivers dependable supply and competitive trade margins.
Monopoly PCD Franchise
Secure exclusive district distribution rights for DELOTRIL-0.25 and the complete Blessme Neuro catalog with promotional visual aids, doctor samples, and high profit margins.
Third-Party Manufacturing
Turnkey contract manufacturing for Clonazepam MD tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg) with custom batch sizing, stability dossier preparation, and fast delivery timelines.
Hospital & Institutional Supply
Direct supply partnerships for psychiatric hospitals, neuropsychiatric clinics, de-addiction centers, and state government health tenders across India.
Blessme · DELOTRIL-0.25
Why Choose DELOTRIL-0.25 (Clonazepam MD 0.25 mg)?
When sourcing Clonazepam MD tablets IP or evaluating dependable clonazepam mouth dissolving tablet brands in India, DELOTRIL-0.25 by Blessme provides exceptional quality, rapid disintegration, and comprehensive B2B support.
WHO-GMP Certified Purity
Manufactured in WHO-GMP and ISO 9001:2015 certified units using pharmacopoeial grade Clonazepam IP, guaranteeing assay precision and fast-melt integrity.
High-Barrier Blister Packaging
Tamper-evident, moisture-resistant 5x4x10 blister strips protect fragile mouth-dissolving tablets from ambient humidity and transit friction.
Pan-India Dispatch from Ahmedabad
Direct factory dispatch from Science City, Ahmedabad with GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.
Monopoly PCD Franchise Rights
Exclusive district-level franchise rights for DELOTRIL-0.25 and the entire Blessme Neuro portfolio with promotional tools, visual aids, and MR bags.
Comprehensive Regulatory Dossiers
Certificates of Analysis (COA), stability testing data, and Material Safety Data Sheets (MSDS) readily available for institutional tenders and hospital audits.
Direct Manufacturer Support
Direct access to Dellwich Lifescience LLP product specialists for quick quotes, customized bulk supply inquiries, and dedicated customer assistance.
Common Questions
Frequently Asked Questions about DELOTRIL-0.25
Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Clonazepam MD Tablets IP 0.25 mg.
What is Clonazepam MD tablet and what is DELOTRIL-0.25?
Clonazepam MD tablet (marketed under the brand name DELOTRIL-0.25 by Blessme, Dellwich Lifescience LLP) is an advanced orally disintegrating / mouth dissolving benzodiazepine medicine. Each tablet contains Clonazepam IP 0.25 mg, engineered to rapidly dissolve on the tongue without requiring water for accelerated absorption and rapid control of panic attacks and anxiety.
What does 'MD' mean in DELOTRIL-0.25?
'MD' stands for Mouth Dissolving (also known as Orally Disintegrating Tablet or ODT). DELOTRIL-0.25 disintegrates in saliva within seconds upon placement on the tongue, allowing pre-gastric absorption through oral and sublingual mucosa. This provides rapid symptom relief during acute anxiety episodes without swallowing difficulties.
What are the primary clinical uses and indications of Clonazepam MD 0.25 mg?
Clonazepam MD 0.25 mg (DELOTRIL-0.25) is clinically prescribed for: (1) acute relief and prevention of panic disorder with or without agoraphobia; (2) generalized anxiety disorder (GAD) and situational anxiety; (3) adjunctive therapy in epileptic seizures, including absence seizures (petit mal), myoclonic seizures, and Lennox-Gastaut syndrome; and (4) initial titration to prevent excessive sedation.
How does Clonazepam MD work in the central nervous system?
Clonazepam acts as a high-affinity positive allosteric modulator on post-synaptic GABA_A receptors in the brain. By enhancing the inhibitory action of gamma-aminobutyric acid (GABA), it increases chloride ion conductance, hyperpolarizing neuronal membranes and dampening abnormal electrical activity in the limbic system, thalamus, and cortex.
Can DELOTRIL-0.25 be purchased over-the-counter without a prescription?
No. Clonazepam is strictly classified as a Schedule H prescription drug and controlled psychotropic substance in India. DELOTRIL-0.25 can only be dispensed against a valid prescription issued by a registered medical practitioner.
What packaging and strip configurations are available for DELOTRIL-0.25?
DELOTRIL-0.25 is packaged in protective 5x4x10 blister strips (200 tablets per carton) made with specialized moisture-resistant foil to preserve the integrity of the delicate fast-melt formulation.
Who manufactures and markets DELOTRIL-0.25 in Ahmedabad, India?
DELOTRIL-0.25 is marketed and distributed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its dedicated neurology and psychiatry portfolio 'Blessme Neuro Products'.
Is PCD pharma franchise available for DELOTRIL-0.25 across India?
Yes. Dellwich Lifescience LLP provides exclusive monopoly-based PCD pharma franchise rights for DELOTRIL-0.25 and the entire Blessme Neuro range, backed by visual aids, sample kits, promotional gifts, and rapid order dispatch.
Why is 0.25 mg preferred for initial Clonazepam therapy?
A 0.25 mg strength represents an ideal micro-titration starting dose. It minimizes common initial side effects such as morning somnolence, motor clumsiness, and cognitive grogginess, allowing the physician to assess therapeutic response before adjusting to 0.5 mg if needed.
What are the common side effects of Clonazepam MD 0.25 mg tablet?
Mild drowsiness, fatigue, dizziness, and slight motor uncoordination may occur, especially during initial therapy. Because of its sedative effect, patients should avoid driving or operating machinery. Dosage must always be tapered gradually under physician guidance.
What is the price of Clonazepam 0.25 mg MD tablet in India?
DELOTRIL-0.25 is an economical, high-quality formulation. For wholesale rate lists, PCD franchise margins, and bulk hospital purchase inquiries, contact Dellwich Lifescience LLP at +91-9909931992 or [email protected].
What is the difference between DELOTRIL-0.25 and DELOTRIL-0.5?
DELOTRIL-0.25 contains 0.25 mg Clonazepam IP, designed for initiating treatment, mild anxiety, and sensitive or elderly patients. DELOTRIL-0.5 contains 0.5 mg Clonazepam IP, prescribed for established panic disorder, acute severe anxiety crises, and seizure maintenance.
Does Dellwich Lifescience provide third-party manufacturing for Clonazepam MD tablets?
Yes. Dellwich Lifescience LLP offers contract and third-party manufacturing for Clonazepam MD tablets across 0.25 mg, 0.5 mg, 1 mg, and 2 mg strengths in WHO-GMP certified facilities with complete stability validation.
Does DELOTRIL-0.25 come with a Certificate of Analysis (COA)?
Yes. Every batch of DELOTRIL-0.25 is accompanied by an authenticated Certificate of Analysis (COA), disintegration time test records, assay confirmation, and MSDS documentation.
Direct Pharmaceutical Enquiry
Need Verified Information or Bulk Supply of DELOTRIL-0.25?
Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.
Direct Manufacturer Pricing & Transparent MOQ
Exclusive PCD Monopoly Rights for Designated Districts
Fast Dispatch from Ahmedabad with GST Invoicing
Comprehensive Marketing, Visual Aids & Promotional Inputs
Quick Assistance & Orders
Enquire About DELOTRIL-0.25
Get bulk pricing, PCD monopoly availability, and technical documentation for Clonazepam MD 0.25 mg.